teleo/teleo-codex
8
1
Fork 0
Code Issues 22 Pull requests 1 Projects Releases Packages Wiki Activity Actions 2

reweave: connect 14 orphan claims via vector similarity
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Details

Browse source 
Threshold: 0.55, Haiku classification, 15 files modified.

Pentagon-Agent: Epimetheus <0144398e-4ed3-4fe2-95a3-3d72e1abf887>
This commit is contained in:
Teleo Agents 2026-05-11 01:19:45 +00:00
parent 633c81add2
commit 1cb75015ca
15 changed files with 55 additions and 1 deletions
Show stats Download patch file Download diff file Expand all files Collapse all files

2
domains/ai-alignment/eu-gpai-requirements-create-extraterritorial-governance-asymmetry-for-us-frontier-labs.md
View file

@ -19,8 +19,10 @@ related:
- eu-ai-act-military-exclusion-gap-limits-governance-scope-to-civilian-systems - eu-ai-act-military-exclusion-gap-limits-governance-scope-to-civilian-systems
supports: supports:
- EU AI Act GPAI evaluation requirements represent the only surviving mandatory governance mechanism targeting frontier AI after the omnibus deferral because systemic-risk model providers face mandatory evaluation risk assessment and AI Office notification from August 2026 while high-risk deployment requirements were deferred 16-24 months - EU AI Act GPAI evaluation requirements represent the only surviving mandatory governance mechanism targeting frontier AI after the omnibus deferral because systemic-risk model providers face mandatory evaluation risk assessment and AI Office notification from August 2026 while high-risk deployment requirements were deferred 16-24 months
- EU GPAI compliance is commercially driven by market access leverage rather than enforcement threat producing minimum-viable documentation compliance
reweave_edges: reweave_edges:
- EU AI Act GPAI evaluation requirements represent the only surviving mandatory governance mechanism targeting frontier AI after the omnibus deferral because systemic-risk model providers face mandatory evaluation risk assessment and AI Office notification from August 2026 while high-risk deployment requirements were deferred 16-24 months|supports|2026-05-10 - EU AI Act GPAI evaluation requirements represent the only surviving mandatory governance mechanism targeting frontier AI after the omnibus deferral because systemic-risk model providers face mandatory evaluation risk assessment and AI Office notification from August 2026 while high-risk deployment requirements were deferred 16-24 months|supports|2026-05-10
- EU GPAI compliance is commercially driven by market access leverage rather than enforcement threat producing minimum-viable documentation compliance|supports|2026-05-11
--- ---
# EU GPAI requirements apply to US frontier AI labs without equivalent domestic US requirements creating a de facto extraterritorial governance asymmetry where AI producers face mandatory EU evaluation that US law does not impose # EU GPAI requirements apply to US frontier AI labs without equivalent domestic US requirements creating a de facto extraterritorial governance asymmetry where AI producers face mandatory EU evaluation that US law does not impose

2
domains/ai-alignment/multilateral-verification-mechanisms-can-substitute-for-failed-voluntary-commitments-when-binding-enforcement-replaces-unilateral-sacrifice.md
View file

@ -14,10 +14,12 @@ attribution:
related: related:
- EU AI Act extraterritorial enforcement can create binding governance constraints on US AI labs through market access requirements when domestic voluntary commitments fail - EU AI Act extraterritorial enforcement can create binding governance constraints on US AI labs through market access requirements when domestic voluntary commitments fail
- Mutually Assured Deregulation makes voluntary AI governance structurally untenable because each actor's restraint creates competitive disadvantage, converting the governance game from cooperation to prisoner's dilemma - Mutually Assured Deregulation makes voluntary AI governance structurally untenable because each actor's restraint creates competitive disadvantage, converting the governance game from cooperation to prisoner's dilemma
- AI verification limits are invoked as corporate safety arguments in government contract disputes rather than just technical research findings
reweave_edges: reweave_edges:
- EU AI Act extraterritorial enforcement can create binding governance constraints on US AI labs through market access requirements when domestic voluntary commitments fail|related|2026-04-06 - EU AI Act extraterritorial enforcement can create binding governance constraints on US AI labs through market access requirements when domestic voluntary commitments fail|related|2026-04-06
- Voluntary safety constraints without external enforcement mechanisms are statements of intent not binding governance because aspirational language with loopholes enables compliance theater while preserving operational flexibility|supports|2026-04-07 - Voluntary safety constraints without external enforcement mechanisms are statements of intent not binding governance because aspirational language with loopholes enables compliance theater while preserving operational flexibility|supports|2026-04-07
- Mutually Assured Deregulation makes voluntary AI governance structurally untenable because each actor's restraint creates competitive disadvantage, converting the governance game from cooperation to prisoner's dilemma|related|2026-04-25 - Mutually Assured Deregulation makes voluntary AI governance structurally untenable because each actor's restraint creates competitive disadvantage, converting the governance game from cooperation to prisoner's dilemma|related|2026-04-25
- AI verification limits are invoked as corporate safety arguments in government contract disputes rather than just technical research findings|related|2026-05-11
supports: supports:
- Voluntary safety constraints without external enforcement mechanisms are statements of intent not binding governance because aspirational language with loopholes enables compliance theater while preserving operational flexibility - Voluntary safety constraints without external enforcement mechanisms are statements of intent not binding governance because aspirational language with loopholes enables compliance theater while preserving operational flexibility
--- ---

3
domains/entertainment/ai-filmmaking-community-develops-institutional-validation-structures-rather-than-replacing-community-with-algorithmic-reach.md
View file

@ -99,7 +99,8 @@ AIF 2026 expands beyond film into New Media, Gaming, Design, Advertising, Fashio
**Source:** Runway AIF 2026 category expansion + Hundred Film Fund status as of April 2026 **Source:** Runway AIF 2026 category expansion + Hundred Film Fund status as of April 2026
AIF 2026 expanded beyond film into New Media, Gaming, Design, Advertising, and Fashion categories, with screenings at Alice Tully Hall (NYC) and The Broad Stage (LA). This expansion into non-film categories while the Hundred Film Fund has not publicly disclosed any funded or completed films after 18 months suggests institutional scaffolding is being built faster than demonstration-quality AI narrative films are being produced. The festival functions as marketing vehicle while actual funded filmmaking remains slower. AIF 2026 expanded beyond film into New Media, Gaming, Design, Advertising, and Fashion categories, with screenings at Alice Tully Hall (NYC) and The Broad Stage (LA). This expansion into non-film categories while the Hundred Film Fund has not publicly disclosed any funded or completed films after 18 months suggests institutional scaffolding is being built faster than demonstration-quality AI narrative films are being produced. The festival functions as marketing vehicle while actual funded filmmaking remains slower.
supports:
- AI film festival ecosystem institutionalizing in 2026 provides cultural validation infrastructure for the disruptive path analogous to Sundance for indie film in the 1990s
--- ---
# AI filmmaking is developing institutional community validation structures rather than replacing community with algorithmic reach # AI filmmaking is developing institutional community validation structures rather than replacing community with algorithmic reach

2
domains/grand-strategy/voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives.md
View file

@ -16,6 +16,7 @@ reweave_edges:
- Voluntary safety constraints without external enforcement mechanisms are statements of intent not binding governance because aspirational language with loopholes enables compliance theater while preserving operational flexibility|supports|2026-04-07 - Voluntary safety constraints without external enforcement mechanisms are statements of intent not binding governance because aspirational language with loopholes enables compliance theater while preserving operational flexibility|supports|2026-04-07
- Legible immediate harm enforces governance convergence independent of competitive incentives because OpenAI implemented access restrictions on GPT-5.5 Cyber identical to Anthropic's Mythos restrictions within weeks of publicly criticizing Anthropic's approach|related|2026-05-05 - Legible immediate harm enforces governance convergence independent of competitive incentives because OpenAI implemented access restrictions on GPT-5.5 Cyber identical to Anthropic's Mythos restrictions within weeks of publicly criticizing Anthropic's approach|related|2026-05-05
- Pentagon exclusion creates EU civilian compliance advantage through pre-aligned safety practices when enforcement proceeds|related|2026-05-05 - Pentagon exclusion creates EU civilian compliance advantage through pre-aligned safety practices when enforcement proceeds|related|2026-05-05
- Hard safety constraints backed by litigation survive government coercion where soft voluntary pledges collapse under competitive pressure|related|2026-05-11
related: related:
- voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives - voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives
- judicial-oversight-of-ai-governance-through-constitutional-grounds-not-statutory-safety-law - judicial-oversight-of-ai-governance-through-constitutional-grounds-not-statutory-safety-law
@ -27,6 +28,7 @@ related:
- independent-ai-evaluation-infrastructure-faces-evaluation-enforcement-disconnect - independent-ai-evaluation-infrastructure-faces-evaluation-enforcement-disconnect
- Legible immediate harm enforces governance convergence independent of competitive incentives because OpenAI implemented access restrictions on GPT-5.5 Cyber identical to Anthropic's Mythos restrictions within weeks of publicly criticizing Anthropic's approach - Legible immediate harm enforces governance convergence independent of competitive incentives because OpenAI implemented access restrictions on GPT-5.5 Cyber identical to Anthropic's Mythos restrictions within weeks of publicly criticizing Anthropic's approach
- Pentagon exclusion creates EU civilian compliance advantage through pre-aligned safety practices when enforcement proceeds - Pentagon exclusion creates EU civilian compliance advantage through pre-aligned safety practices when enforcement proceeds
- Hard safety constraints backed by litigation survive government coercion where soft voluntary pledges collapse under competitive pressure
--- ---
# Voluntary AI safety constraints are protected as corporate speech but unenforceable as safety requirements, creating legal mechanism gap when primary demand-side actor seeks safety-unconstrained providers # Voluntary AI safety constraints are protected as corporate speech but unenforceable as safety requirements, creating legal mechanism gap when primary demand-side actor seeks safety-unconstrained providers

4
domains/health/ibogaine-federal-policy-priority-rests-on-single-n30-pilot-illustrating-veteran-constituency-acceleration-ahead-of-evidence-hierarchy.md
View file

@ -11,6 +11,10 @@ sourced_from: health/2024-xx-stanford-ibogaine-veterans-ptsd-n30.md
scope: structural scope: structural
sourcer: Stanford University School of Medicine / CNN / NPR sourcer: Stanford University School of Medicine / CNN / NPR
related: ["healthcare-ai-regulation-needs-blank-sheet-redesign", "the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access"] related: ["healthcare-ai-regulation-needs-blank-sheet-redesign", "the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access"]
supports:
- Stanford Ibogaine Veterans Study
reweave_edges:
- Stanford Ibogaine Veterans Study|supports|2026-05-11
--- ---
# Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies # Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies

6
domains/health/ibogaine-iv-magnesium-protocol-demonstrates-cardiac-risk-manageable-in-supervised-settings-addressing-primary-safety-barrier.md
View file

@ -11,6 +11,12 @@ sourced_from: health/2024-xx-stanford-ibogaine-veterans-ptsd-n30.md
scope: functional scope: functional
sourcer: Stanford University School of Medicine sourcer: Stanford University School of Medicine
related: ["healthcare-ai-regulation-needs-blank-sheet-redesign"] related: ["healthcare-ai-regulation-needs-blank-sheet-redesign"]
supports:
- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies
- Stanford Ibogaine Veterans Study
reweave_edges:
- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies|supports|2026-05-11
- Stanford Ibogaine Veterans Study|supports|2026-05-11
--- ---
# IV magnesium protocol demonstrates ibogaine's cardiac risk is manageable in supervised clinical settings addressing the primary safety barrier to Phase 3 trials # IV magnesium protocol demonstrates ibogaine's cardiac risk is manageable in supervised clinical settings addressing the primary safety barrier to Phase 3 trials

4
domains/health/mdma-assisted-therapy-functional-unblinding-invalidates-self-reported-outcomes-despite-phase3-efficacy.md
View file

@ -11,6 +11,10 @@ sourced_from: health/2024-08-09-fda-mdma-ptsd-complete-response-letter-lykos.md
scope: structural scope: structural
sourcer: FDA / Psychiatric Times / STAT News sourcer: FDA / Psychiatric Times / STAT News
related: ["prescription-digital-therapeutics-failed-as-a-business-model-because-fda-clearance-creates-regulatory-cost-without-the-pricing-power-that-justifies-it-for-near-zero-marginal-cost-software"] related: ["prescription-digital-therapeutics-failed-as-a-business-model-because-fda-clearance-creates-regulatory-cost-without-the-pricing-power-that-justifies-it-for-near-zero-marginal-cost-software"]
supports:
- Psychedelic therapy regulatory approval requires either active comparator designs or objective endpoints because highly psychoactive compounds create functional unblinding that invalidates self-reported psychiatric outcomes
reweave_edges:
- Psychedelic therapy regulatory approval requires either active comparator designs or objective endpoints because highly psychoactive compounds create functional unblinding that invalidates self-reported psychiatric outcomes|supports|2026-05-11
--- ---
# MDMA-assisted therapy's FDA rejection reveals that clinical efficacy is necessary but insufficient for regulatory approval when functional unblinding invalidates self-reported outcomes in psychiatry trials # MDMA-assisted therapy's FDA rejection reveals that clinical efficacy is necessary but insufficient for regulatory approval when functional unblinding invalidates self-reported outcomes in psychiatry trials

4
domains/health/psilocybin-achieves-positive-phase3-trd-single-dose-26week-durability.md
View file

@ -12,6 +12,10 @@ scope: causal
sourcer: Compass Pathways sourcer: Compass Pathways
challenges: ["prescription-digital-therapeutics-failed-as-a-business-model-because-fda-clearance-creates-regulatory-cost-without-the-pricing-power-that-justifies-it-for-near-zero-marginal-cost-software"] challenges: ["prescription-digital-therapeutics-failed-as-a-business-model-because-fda-clearance-creates-regulatory-cost-without-the-pricing-power-that-justifies-it-for-near-zero-marginal-cost-software"]
related: ["the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access", "prescription-digital-therapeutics-failed-as-a-business-model-because-fda-clearance-creates-regulatory-cost-without-the-pricing-power-that-justifies-it-for-near-zero-marginal-cost-software", "antidepressant-discontinuation-follows-continuous-treatment-model-but-psychological-support-mitigates-relapse"] related: ["the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-than-expanding-access", "prescription-digital-therapeutics-failed-as-a-business-model-because-fda-clearance-creates-regulatory-cost-without-the-pricing-power-that-justifies-it-for-near-zero-marginal-cost-software", "antidepressant-discontinuation-follows-continuous-treatment-model-but-psychological-support-mitigates-relapse"]
supports:
- Trump's April 2026 Executive Order on psychedelics represents the first federal bipartisan commitment to Schedule I psychedelic drug development pathways, signaling regulatory environment shift that de-risks clinical investment through existing frameworks rather than new legislation
reweave_edges:
- Trump's April 2026 Executive Order on psychedelics represents the first federal bipartisan commitment to Schedule I psychedelic drug development pathways, signaling regulatory environment shift that de-risks clinical investment through existing frameworks rather than new legislation|supports|2026-05-11
--- ---
# Psilocybin achieves positive Phase 3 evidence for treatment-resistant depression with single-dose 26-week durability representing the first FDA-approvable psychedelic # Psilocybin achieves positive Phase 3 evidence for treatment-resistant depression with single-dose 26-week durability representing the first FDA-approvable psychedelic

9
domains/health/psychedelic-therapy-regulatory-success-requires-active-comparator-or-objective-endpoints-for-highly-psychoactive-compounds.md
View file

@ -10,6 +10,15 @@ agent: vida
sourced_from: health/2024-08-09-fda-mdma-ptsd-complete-response-letter-lykos.md sourced_from: health/2024-08-09-fda-mdma-ptsd-complete-response-letter-lykos.md
scope: structural scope: structural
sourcer: FDA / Psychiatric Times / STAT News sourcer: FDA / Psychiatric Times / STAT News
supports:
- MDMA-assisted therapy's FDA rejection reveals that clinical efficacy is necessary but insufficient for regulatory approval when functional unblinding invalidates self-reported outcomes in psychiatry trials
reweave_edges:
- MDMA-assisted therapy's FDA rejection reveals that clinical efficacy is necessary but insufficient for regulatory approval when functional unblinding invalidates self-reported outcomes in psychiatry trials|supports|2026-05-11
- Psilocybin achieves positive Phase 3 evidence for treatment-resistant depression with single-dose 26-week durability representing the first FDA-approvable psychedelic|related|2026-05-11
- Psilocybin therapy requires psychological support as an embedded clinical protocol component not an optional adjunct|related|2026-05-11
related:
- Psilocybin achieves positive Phase 3 evidence for treatment-resistant depression with single-dose 26-week durability representing the first FDA-approvable psychedelic
- Psilocybin therapy requires psychological support as an embedded clinical protocol component not an optional adjunct
--- ---
# Psychedelic therapy regulatory approval requires either active comparator designs or objective endpoints because highly psychoactive compounds create functional unblinding that invalidates self-reported psychiatric outcomes # Psychedelic therapy regulatory approval requires either active comparator designs or objective endpoints because highly psychoactive compounds create functional unblinding that invalidates self-reported psychiatric outcomes

4
domains/health/trump-2026-psychedelic-executive-order-creates-bipartisan-regulatory-acceleration-through-existing-frameworks.md
View file

@ -12,6 +12,10 @@ scope: structural
sourcer: White House / FDA sourcer: White House / FDA
challenges: ["healthcare-ai-regulation-needs-blank-sheet-redesign"] challenges: ["healthcare-ai-regulation-needs-blank-sheet-redesign"]
related: ["healthcare-ai-regulation-needs-blank-sheet-redesign", "fda-2026-cds-enforcement-discretion-expands-to-single-recommendation-ai-without-defining-clinical-appropriateness"] related: ["healthcare-ai-regulation-needs-blank-sheet-redesign", "fda-2026-cds-enforcement-discretion-expands-to-single-recommendation-ai-without-defining-clinical-appropriateness"]
supports:
- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies
reweave_edges:
- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies|supports|2026-05-11
--- ---
# Trump's April 2026 Executive Order on psychedelics represents the first federal bipartisan commitment to Schedule I psychedelic drug development pathways, signaling regulatory environment shift that de-risks clinical investment through existing frameworks rather than new legislation # Trump's April 2026 Executive Order on psychedelics represents the first federal bipartisan commitment to Schedule I psychedelic drug development pathways, signaling regulatory environment shift that de-risks clinical investment through existing frameworks rather than new legislation

2
domains/internet-finance/genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers.md
View file

@ -12,9 +12,11 @@ sourcer: Nellie Liang, Brookings Institution
related: related:
- GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination
- GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter - GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter
- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield
reweave_edges: reweave_edges:
- GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination|related|2026-04-18 - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination|related|2026-04-18
- GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter|related|2026-04-18 - GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter|related|2026-04-18
- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield|related|2026-05-11
--- ---
# GENIUS Act public company restriction creates asymmetric Big Tech barrier while permitting private non-financial issuers # GENIUS Act public company restriction creates asymmetric Big Tech barrier while permitting private non-financial issuers

2
domains/internet-finance/genius-act-reserve-custody-creates-indirect-banking-dependency-for-nonbank-stablecoin-issuers.md
View file

@ -15,10 +15,12 @@ supports:
related: related:
- GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination
- genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers - genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers
- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield
reweave_edges: reweave_edges:
- GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination|related|2026-04-18 - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination|related|2026-04-18
- genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers|related|2026-04-18 - genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers|related|2026-04-18
- national-trust-charters-enable-crypto-exchanges-to-bypass-congressional-gridlock-through-federal-banking-infrastructure|supports|2026-04-18 - national-trust-charters-enable-crypto-exchanges-to-bypass-congressional-gridlock-through-federal-banking-infrastructure|supports|2026-04-18
- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield|related|2026-05-11
--- ---
# GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter # GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter

4
domains/space-development/amazon-kuiper-selective-governance-participation-reveals-strategic-preference-for-flexible-principles-over-mandatory-operational-rules.md
View file

@ -11,6 +11,10 @@ sourced_from: space-development/2026-05-10-spacenews-amazon-kuiper-wef-guideline
scope: functional scope: functional
sourcer: LightReading / About Amazon sourcer: LightReading / About Amazon
related: ["spacex-refusal-to-endorse-wef-debris-governance-instantiates-voluntary-governance-failure-in-orbital-commons", "fcc-orbital-debris-governance-applies-competitive-market-logic-to-commons-externality-problem"] related: ["spacex-refusal-to-endorse-wef-debris-governance-instantiates-voluntary-governance-failure-in-orbital-commons", "fcc-orbital-debris-governance-applies-competitive-market-logic-to-commons-externality-problem"]
supports:
- SpaceX and Amazon Kuiper non-endorsement of WEF debris guidelines demonstrates systemic voluntary governance failure at the scale where it matters most
reweave_edges:
- SpaceX and Amazon Kuiper non-endorsement of WEF debris guidelines demonstrates systemic voluntary governance failure at the scale where it matters most|supports|2026-05-11
--- ---
# Amazon Kuiper selective governance participation reveals strategic preference for flexible principles-based frameworks over mandatory operational rules # Amazon Kuiper selective governance participation reveals strategic preference for flexible principles-based frameworks over mandatory operational rules

6
entities/health/stanford-ibogaine-veterans-study.md
View file

@ -4,6 +4,12 @@ entity_type: research_program
name: Stanford Ibogaine Veterans Study name: Stanford Ibogaine Veterans Study
domain: health domain: health
status: completed status: completed
supports:
- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies
- IV magnesium protocol demonstrates ibogaine's cardiac risk is manageable in supervised clinical settings addressing the primary safety barrier to Phase 3 trials
reweave_edges:
- Ibogaine's federal policy priority in 2026 rests on a single n=30 pilot study illustrating how veteran political constituencies can accelerate regulatory posture ahead of evidence hierarchies|supports|2026-05-11
- IV magnesium protocol demonstrates ibogaine's cardiac risk is manageable in supervised clinical settings addressing the primary safety barrier to Phase 3 trials|supports|2026-05-11
--- ---
# Stanford Ibogaine Veterans Study # Stanford Ibogaine Veterans Study

2
entities/internet-finance/genius-act.md
View file

@ -21,10 +21,12 @@ related:
- GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination
- genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers - genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers
- GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter - GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter
- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield
reweave_edges: reweave_edges:
- GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination|related|2026-04-18 - GENIUS Act freeze/seize requirement creates mandatory control surface that conflicts with autonomous smart contract payment coordination|related|2026-04-18
- genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers|related|2026-04-18 - genius-act-public-company-restriction-creates-asymmetric-big-tech-barrier-while-permitting-private-non-financial-issuers|related|2026-04-18
- GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter|related|2026-04-18 - GENIUS Act reserve custody rules create indirect banking system dependency for nonbank stablecoin issuers without requiring bank charter|related|2026-04-18
- GENIUS Act stablecoin yield prohibition reveals rent-protection motive because White House economists find negligible lending protection ($2.1B baseline, $531B worst-case) while consumers lose $800M annually in forgone yield|related|2026-05-11
--- ---
# GENIUS Act (Guiding and Establishing National Innovation for U.S. Stablecoins of 2025) # GENIUS Act (Guiding and Establishing National Innovation for U.S. Stablecoins of 2025)